9月16日,据深圳证券交易所披露,深圳证券交易所上市审核委员会2026年第54次审议会议召开,广东博迈医疗科技股份有限公司(简称“博迈医疗”)首次公开发行股票并在创业板上市申请通过审核。公司保荐机构(主承销商)为中国国际金融股份有限公司。 招股说明书(上会稿)披露的信息显示,博迈医疗成立于2012年3月,注册资本5782.0355万元,法定代表人为李斌。公司专注于高性能血管介入医疗器械的研发、生产...
Source Link9月16日,据深圳证券交易所披露,深圳证券交易所上市审核委员会2026年第54次审议会议召开,广东博迈医疗科技股份有限公司(简称“博迈医疗”)首次公开发行股票并在创业板上市申请通过审核。公司保荐机构(主承销商)为中国国际金融股份有限公司。 招股说明书(上会稿)披露的信息显示,博迈医疗成立于2012年3月,注册资本5782.0355万元,法定代表人为李斌。公司专注于高性能血管介入医疗器械的研发、生产...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.